HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for treatment of cholangiocarcinoma
Journal article published in 2018 by
Dante Lamberti,
Giulia Cristinziano,
Manuela Porru,
Carlo Leonetti,
Jan B. Egan,
Chang-Xin Shi,
Simonetta Buglioni,
Carla A. Amoreo,
Loriana Castellani,
Mitesh J. Borad,
Stefano Alemà,
Sergio Anastasi,
Oreste Segatto 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 